Daisuke Sueta

Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Exploring oxidative modifications of tyrosine: An update on mechanisms of formation, advances in analysis and biological consequences

Vascular dementia

ROS in cancer therapy: the bright side of the moon

The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease

Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sex and gender: modifiers of health, disease, and medicine

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

The role of antioxidants in the chemistry of oxidative stress: A review

Gout

Pre-clinical models of human cerebral small vessel disease: Utility for clinical application

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus

Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease

The Pathobiology of Vascular Dementia

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Microvascular Dysfunction and Cognitive Impairment

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

Physiology and Pathophysiology of Carnosine

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders

Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?

Gout and the risk of dementia: a nationwide population-based cohort study

Protective Effect of Carnosine on Subcortical Ischemic Vascular Dementia in Mice

DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Beneficial Effects of Combination of Valsartan and Amlodipine on Salt-Induced Brain Injury in Hypertensive Rats

Impact of aspirin on the prognosis in patients with coronary spasm without significant atherosclerotic stenosis

Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion

Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease

Renal Denervation Prevents Stroke and Brain Injury via Attenuation of Oxidative Stress in Hypertensive Rats